Cytokines and growth factors have prominent roles in liver regeneration. The aim of this study was to evaluate the biological markers of liver regeneration in healthy donors undergoing right lobe donor hepatectomy for living donor liver transplantation. Twenty-five voluntary liver donors were enrolled. Peripheral blood samples were taken a day before the operation and on postoperative days (PODs) 1, 3, 7, 14, and 42. Levels of hepatocyte growth factor (HGF), interleukin (IL) 6, tumor necrosis factor a (TNF-a), thrombopoietin (TPO), transforming growth factor b1 (TGF-b1), interferon (IFN) a, and IFNg were monitored. The remnant liver volume (RLV) before surgery and regeneration liver volume (RgV) on POD 14 were calculated on computed tomography (CT). RgV/RLV ratio was correlated with the remnant-liver-volume-to-body-weight ratio (RLVBWR). Inverse correlation was observed between RgV/RLV and RLVBWR (r 2 5 0.61; P < 0.001). There was a significant rise of HGF on POD 1 (P 5 0.001), POD 7 (P 5 0.049), and POD 14 (P 5 0.04). TNF-a was elevated on POD 1 (P 5 0.004). The levels of IL 6 (P < 0.001) and TPO (P < 0.001) were higher from POD 1 to POD 42. IFNa was higher on POD 14 (P 5 0.003) and POD 42 (P 5 0.001). There was a significant fall of IFNg on POD 1 (P 5 0.01) and increase on POD 14 (P 5 0.04). The levels of TGF-b1 were higher on POD 14 (P 5 0.008) and on POD 42 (P 5 0.002). In conclusion, HGF, IL 6, TNF-a, and TPO are involved in the early phase, whereas TGF-b1 and IFN are involved in the termination phase of liver regeneration. Liver regeneration was observed to be higher in donors with low RLVBWR. Liver Transpl 22:344-351, 2016. V C 2015 AASLD.